{
    "2021-01-11": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：从历史复盘看“高景气度龙头”抱团趋势",
                "features": {
                    "keywords": [
                        "医药",
                        "行业",
                        "高景气度",
                        "龙头",
                        "抱团趋势"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：维持行业长期看好观点 持续关注创新与高景气细分领域",
                "features": {
                    "keywords": [
                        "医药",
                        "行业",
                        "长期看好",
                        "创新",
                        "高景气",
                        "细分领域"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "长春高新：部分董事高管拟合计减持不超6.37万股 拟减持股份数量",
                "features": {
                    "keywords": [
                        "长春高新",
                        "董事",
                        "高管",
                        "减持",
                        "股份数量"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "长春高新：部分董事、高级管理人员计划合计减持不超过0.0157%股份 拟减持股份数量",
                "features": {
                    "keywords": [
                        "长春高新",
                        "董事",
                        "高管",
                        "减持",
                        "股份比例"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "春季躁动！154家公司业绩翻番，年报行情成重头戏",
                "features": {
                    "keywords": [
                        "春季躁动",
                        "公司",
                        "业绩翻番",
                        "年报行情"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物/行业周报：关注业绩超预期的机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业",
                        "业绩超预期",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "753家公司预告2020年报业绩，近半数预喜",
                "features": {
                    "keywords": [
                        "公司",
                        "年报业绩",
                        "预告",
                        "预喜"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}